Comparison 3. Superinfections.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Any superinfections	10	1896	Risk Ratio (M‐H, Fixed, 95% CI)	0.84 [0.66, 1.08]
1.1 Glycopeptide	6	1281	Risk Ratio (M‐H, Fixed, 95% CI)	0.87 [0.67, 1.13]
1.2 Other antiGP	4	615	Risk Ratio (M‐H, Fixed, 95% CI)	0.73 [0.38, 1.40]
2 Bacterial superinfections	9	1992	Risk Ratio (M‐H, Fixed, 95% CI)	0.41 [0.27, 0.60]
2.1 Glycopeptide	5	1296	Risk Ratio (M‐H, Fixed, 95% CI)	0.38 [0.24, 0.59]
2.2 Other antiGP	4	696	Risk Ratio (M‐H, Fixed, 95% CI)	0.52 [0.23, 1.15]
3 Gram‐positive superinfections	9	1688	Risk Ratio (M‐H, Fixed, 95% CI)	0.24 [0.14, 0.40]
3.1 Glycopeptide	6	1356	Risk Ratio (M‐H, Fixed, 95% CI)	0.21 [0.11, 0.37]
3.2 Other antiGP	3	332	Risk Ratio (M‐H, Fixed, 95% CI)	0.46 [0.15, 1.45]
4 Fungal superinfections	9	1637	Risk Ratio (M‐H, Fixed, 95% CI)	1.10 [0.69, 1.77]
4.1 Glycopeptide	6	1305	Risk Ratio (M‐H, Fixed, 95% CI)	1.18 [0.70, 1.99]
4.2 Other antiGP	3	332	Risk Ratio (M‐H, Fixed, 95% CI)	0.82 [0.27, 2.48]